MIRO: a randomized trial of maintenance therapy with or whitout protease inhibitors after 4 months of triple or quadruple induction therapy
Nathan Clumeck(Centre Hospitalier Universitaire de Saint-Pierre), Stéphane De Wit(Université Libre de Bruxelles), Bernadette Sommereijns, Kabamba Kabeya, Déborah Konopnicki(Université Libre de Bruxelles), Pascal Pierre, Jean‐Paul Van Vooren(Université Libre de Bruxelles), Jean Legrand, S Sprecher, Philippe Hermans(Centre Hospitalier Universitaire de Saint-Pierre), Nankavu-Jeanne Mundere, Elizabeth O'Doherty, Claire‐Michèle Farber
Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles)
January 1, 1998
Cited by 5
Related Papers
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
|Hepatology|2006|4.8k
B cell–helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen
|Nature Immunology|2011|724
Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) Study
|The Journal of Infectious Diseases|2009|649
Immunogenicity and protective efficacy of a tuberculosis DNA vaccine
|Nature Medicine|1996|632